WallStreetZenWallStreetZen

NASDAQ: DRS
Leonardo Drs Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DRS past earnings growth

How has DRS's earnings growth performed historically?
Company
-65.96%
Industry
3.31%
Market
105.88%
DRS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DRS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

DRS past revenue growth

How has DRS's revenue growth performed historically?
Company
4.94%
Industry
12.14%
Market
17.29%
DRS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DRS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DRS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DRS earnings and revenue history

Current Revenue
$2.8B
Current Earnings
$168.0M
Current Profit Margin
5.9%

DRS Return on Equity

Current Company
7.6%
Current Industry
12.6%
Current Market
188%
DRS's Return on Equity (7.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DRS announces earnings.

DRS Return on Assets

Current Company
4.5%
Current Industry
3.7%
DRS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DRS Return on Capital Employed

Current Company
8.02%
Current Industry
9%
DRS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DRS vs Defense Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DRS$2.83B$313.00M$168.00M+3.91%+5.33%
HXL$1.80B$266.00M$99.50M-4.40%-18.55%
CAE$3.33B$662.00M$206.37M+8.72%-4.12%
MOG.A$3.42B$378.00M$172.79M+4.34%+6.97%
ERJ$5.27B$684.00M$164.00M+0.77%N/A
View Top Defense Stocks

DRS earnings dates

Next earnings date
May 1, 2024

Leonardo Drs Earnings & Revenue FAQ

What were DRS's earnings last quarter?

On Invalid Date, Leonardo Drs (NASDAQ: DRS) reported Q4 2023 earnings per share (EPS) of $0.28, up 7.69% year over year. Total Leonardo Drs earnings for the quarter were $74.00 million. In the same quarter last year, Leonardo Drs's earnings per share (EPS) was $0.26.

If you're new to stock investing, here's how to buy Leonardo Drs stock.

What was DRS's earnings growth in the past year?

As of Q2 2024, Leonardo Drs's earnings has grown -65.96% year over year. This is 69.27 percentage points lower than the US Aerospace & Defense industry earnings growth rate of 3.31%. Leonardo Drs's earnings in the past year totalled $168.00 million.

What is DRS's earnings date?

Leonardo Drs's earnings date is Invalid Date. Add DRS to your watchlist to be reminded of DRS's next earnings announcement.

What was DRS's revenue last quarter?

On Invalid Date, Leonardo Drs (NASDAQ: DRS) reported Q4 2023 revenue of $926.00 million up 12.93% year over year. In the same quarter last year, Leonardo Drs's revenue was $820.00 million.

What was DRS's revenue growth in the past year?

As of Q2 2024, Leonardo Drs's revenue has grown 4.94% year over year. This is 7.2 percentage points lower than the US Aerospace & Defense industry revenue growth rate of 12.14%. Leonardo Drs's revenue in the past year totalled $2.83 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.